Detalles de la búsqueda
1.
The enduring metabolic improvement of combining dual amylin and calcitonin receptor agonist and semaglutide treatments in a rat model of obesity and diabetes.
Am J Physiol Endocrinol Metab
; 2024 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38864815
2.
Dual amylin and calcitonin receptor agonist treatment reduces biomarkers associated with kidney fibrosis in diabetic rats.
Am J Physiol Endocrinol Metab
; 325(5): E529-E539, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37792041
3.
The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile.
BMC Endocr Disord
; 21(1): 10, 2021 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33413317
4.
Dose Frequency Optimization of the Dual Amylin and Calcitonin Receptor Agonist KBP-088: Long-Lasting Improvement in Food Preference and Body Weight Loss.
J Pharmacol Exp Ther
; 373(2): 269-278, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32071103
5.
The Calcitonin Receptor Plays a Major Role in Glucose Regulation as a Function of Dual Amylin and Calcitonin Receptor Agonist Therapy.
J Pharmacol Exp Ther
; 374(1): 74-83, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32317372
6.
The Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin Action.
J Pharmacol Exp Ther
; 373(1): 92-102, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31992608
7.
The Dual Amylin and Calcitonin Receptor Agonist KBP-088 Induces Weight Loss and Improves Insulin Sensitivity Superior to Chronic Amylin Therapy.
J Pharmacol Exp Ther
; 370(1): 35-43, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31028106
8.
Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long-acting dual amylin and calcitonin receptor agonist improves insulin-mediated glycaemic control and controls body weight.
Br J Pharmacol
; 181(12): 1829-1842, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38378168
9.
Dual amylin and calcitonin receptor agonist treatment improves insulin sensitivity and increases muscle-specific glucose uptake independent of weight loss.
Biomed Pharmacother
; 164: 114969, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37269811
10.
The Impact of Exposure Profile on the Efficacy of Dual Amylin and Calcitonin Receptor Agonist Therapy.
Biomedicines
; 10(10)2022 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36289629
Resultados
1 -
10
de 10
1
Próxima >
>>